期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | INDIAN JOURNAL OF PHARMACOLOGY LetPub Score 4.9
50 ratings
Rate
Reputation 6.4 Influence 3.3 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | INDIAN J PHARMACOL | ||||||||||||||||||||
ISSN | 0019-5472 | ||||||||||||||||||||
E-ISSN | 1998-3751 | ||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.ijpsonline.com/ | ||||||||||||||||||||
在線稿件提交 | http://www.ijpsonline.com/submit-article.html | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wolters Kluwer Health | ||||||||||||||||||||
主題領域 | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||
出版國/地區 | India | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1939 | ||||||||||||||||||||
每年文章數 | 60每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0019-5472%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: 0% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[INDIAN JOURNAL OF PHARMACOLOGY] 的評論 | 撰寫評論 |
作者: 百花菱凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-12 23:15:53 評論於 None(0) 讚! | 百花菱凡 |
作者: 水月淑霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-28 22:30:02 評論於 Is there a template for the ethical approval document of this journal?(0) 讚! | 水月淑霞 |
作者: 百花菱凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-16 08:09:41 評論於 The application submitted in September 2022 will be processed in July 2023. If you are not in a hurry, you may receive a pleasant surprise(0) 讚! | 百花菱凡 |
作者: Colin Tobias 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-15 20:56:38 評論於 It has been 449 days since it was repaired, but they never respond to emails(0) 讚! | Colin Tobias |
作者: Colin Tobias 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-14 14:36:45 評論於 Review Speed: 24.0 Emphasis of Research Direction: Pharmacology Experience of sharing: Very, very slow, it has been 425 days, and there has been no final decision after revision. Emails are never replied to(0) 讚! | Colin Tobias |
作者: 子昂公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 12:11:18 評論於 I would like to ask how much the layout fee is(0) 讚! | 子昂公子 |
作者: 子昂公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-19 08:52:25 評論於 I would like to ask how much the layout fee is(0) 讚! | 子昂公子 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:04:34 評論於 Every study is inevitably limited by its research constraints. Factors such as research design and research methods can contribute to these limitations(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:56:27 評論於 There is no fixed requirement for paragraphing in the discussion, so feel free to write based on your own situation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 09:29:18 評論於 What are the limitations of the article?(0) 讚! | 上清雨真 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-25 10:58:52 評論於 How many paragraphs are typically included in a discussion?(0) 讚! | 龙鳞孝礼 |
作者: 季雅mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-02-24 21:42:08 評論於 Review speed: 24.0 | Submission acceptance rate: 75.0 Experience sharing: Too slow. It took me 461 days from submission to acceptance(0) 讚! | 季雅mm |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 10:59:08 評論於 Anyway, it's unlikely that the situation will change, so as long as it doesn't get worse, that's fortunate(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-31 08:51:55 評論於 Wow, this magazine is unbelievably slow. I submitted my article in August last year, it has gone through two rounds of status updates and is still under review. I have followed up twice but still no response. This is so frustrating(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-01-14 12:58:26 評論於 Review speed: 3.0 | Submission hit rate: 25.0 Experience sharing: The acceptance rate in 2013 was 7%, with few submissions from Chinese authors. The review speed is relatively slow, but the editors are very meticulous. If your article is not too profound but has some innovation, you can consider submitting it. However, if it's urgent, it's not recommended to submit. After submitting my article, it was accepted after 6 months. It has been proofread but not yet published(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us